首页>The journal of clinical hypertension>Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
作者单位：Daiichi Sankyo, Inc, Parsippany, NJ, United States[1]Oklahoma Cardiovascular and Hypertension Center, University of Oklahoma College of Medicine[2]State University of New York at Buffalo, Buffalo, NY, United States[3]Piedmont Medical Research Associates, Winston-Salem, NC, United States[4]The Christ Hospital Heart and Vascular Center, The Carl and Edyth Lindner Center for Research and[5]University of Alabama at Birmingham, Birmingham, AL, United States[6]
换一批
